Innovation for a lifetime of hearing

This is the Cochlear ™ promise to you. As the global leader in hearing
solutions, Cochlear is dedicated to bringing the gift of sound to people all
over the world. With our hearing solutions, Cochlear has reconnected over
250,000 cochlear implant and Baha® recipients to their families, friends and
communities in more than 100 countries.
Along with the industry’s largest investment in research and development,
we continue to partner with leading international researchers and hearing
professionals, ensuring that we are at the forefront in the science of hearing.
For the person with hearing loss receiving any one of the Cochlear hearing
solutions, our commitment is that for the rest of your life we will be here to
support you Hear now. And always
www.CochlearAmericas.com
Cochlear Americas
13059 East Peakview Avenue
Centennial, CO 80111 USA
Tel:
1 303 790 9010
Fax: 1 303 792 9025
Toll Free: 1 800 523 5798
© 2012. The products and services referenced are trademarks or registered trademarks of
Cochlear Limited or Cochlear Bone Anchored Solutions. The names of actual companies
and products mentioned herein may be the trademarks of their respective owners.
FUN1579 ISS1 APR12
Innovation for a lifetime of hearing
1960
Per Ingvar Branemark
discovers titanium
integration with bone.
1977
Professor Graeme Clark
receives research grant for
“The Development
of a Hearing Prosthesis.”
Professor Clark discovers
how to securely place the
electrode in the inner ear by
experimenting
with a blade
of grass
and a small
sea shell.
1965
Mona
Andersson,
First Baha
recipient.
1967
Graeme Clark begins
researching an electronic
implantable hearing device.
Dr Graeme Clark appointed
Professor and Chairman,
Dept. of Otolaryngology,
The University of
Melbourne.
First multi-channel research
implant is developed. Rod
Saunders becomes the first
recipient. He
recognized the
tune of
Waltzing
Matilda.
1979
1977
Engineers Jim Patrick and
Ian Forster present the
circuit diagram for the
first Bionic ear.
1981
Paul Trainor is given
AU $4 million to start
commercial development of
the multi-channel cochlear
implant, bringing
the first Nucleus
cochlear implant
to commercial
market.
Rod Saunders uses a
Portable Sound Processor.
1981
1977
First medical application
of titanium implant by
Branemark.
1970
1978
Cochlear global headquarters
established in Sydney, Australia.
A medical device group,
Nucleus, Cochlear and the
Australian Government
partner together to develop
a commercially available
cochlear implant.
1982
The first commercial
Nucleus implant (Nucleus
CI22). The recipient was
Graham Carrick,
aged 37 yrs.
1980
Portable Sound Processor
with magnet-less headset
is created, George Watson
becomes the Second
Recipient.
1984
1992
Cochlear Americas office
established outside Denver,
Colorado.
One of the first pediatric
cochlear implant recipients
Pia Jeffrey is featured on the
Sydney Telephone Directory.
Her picture was taken by
a local newspaper and
captured the moment
when she first
heard sound
– “her face
lit up!”
1985
The Nucleus Mini22 implant
with the WSP (Wearable
Sound Processor) was the
first multichannel
device to
receive FDA
pre-market
application
approval.
First Nucleus cochlear
implant surgery takes place
in Japan.
1985–1986
The first two research
pediatric cochlear implant
procedures take place.
Clinical trials for children
begin in the US.
1987
Holly McDonell, at the age
of four, is the first pediatric
recipient of a commercial
Nucleus cochlear implant.
She still has her original
implant and has had five
sound processor upgrades.
1989
Nucleus 22
recipients
are upgraded
from their
original WSP to the smaller
Mini Sound Processor (MSP).
1990
1982
Rod Saunders upgrades
to a new Wearable Sound
Processor.
Scott Smith on right (10 years) and
Bryn Davies (5 years) on left
US FDA approves Nucleus
Cochlear Implant system
for children
age 2-17.
1967
1977
1979
1981
1985
1987
1997–1998
The first implant capable
of performing Neural
Response Telemetry (NRT),
used to provide an objective
measurement of the
hearing nerve’s response to
electrical stimulation (NRT).
1992
1994
Cochlear celebrates the
10,000th Nucleus recipient.
1994
Spectra processor upgrade
for Nucleus 22 users. This
utilizes SPEAK, an improved
speech coding strategy
providing fuller, richer, more
natural sound.
1992
1998
Nucleus 24 cochlear
implant released. The new
implant offers technical
advancements including an
electrode designed to
provide more direct
stimulation.
The first MRI-safe
implant up to 1.5
Tesla is introduced.
1998
The first multi-channel BTE
processor introduced – the
ESPrit. A sound processor
worn entirely behind the
ear, freeing recipients
from long cables and
extra components.
1995
2001
Nucleus 24 Contour Advance
is introduced. Unique
Softip™ feature designed to
protect delicate cochlea.
2002
2000
Nucleus 24 Contour
perimodiolar electrode array
is introduced and receives
the Australian Design Award.
1998
20,000th person receives a
Nucleus cochlear implant.
1999
The Baha System is approved
for implantation in children 5
years of age or older.
Cochlear celebrates the
5,000th Nucleus recipient.
The Baha System is first
cleared by the FDA for
treatment of mixed and
conductive hearing losses.
The Bionic Ear Stamp release
by the Australian Postal Service.
Cochlear becomes listed
on the Australian Stock
Exchange (ASX)
SPrint is introduced,
the technology is based on
a powerful Digital Signal
Processor
(DSP).
1995
1987
1995
1999–2000
Nucleus ACE speech
coding trategy developed.
Combining the benefits of
pitch information of the
SPEAK strategy, with the
higher rates of stimulation
offered by the CIS strategy.
ESPrit 22 BTE sound
processor is released. The
fourth upgrade for Nucleus
22 recipients. Sets industry
standard of a Lifetime
Commitment in providing
a BTE option for recipients
implanted many years before.
ESPrit 3G introduced as
part of the new Nucleus 3
system. The new behindthe-ear processor is
compatible with Nucleus 24
and Contour implants. ESPrit
3G is the first processor with
a built-in telecoil, making
phone use more accessible.
30,000th Nucleus
Recipient. BJ Perez
of San Antonio
2001
Cochlear celebrates the
30,000th Nucleus Recipient.
2002
The Graeme Clark scholarship
aims to support cochlear
implant recipients who wish
to further their education with
University studies.
2005
Baha Divino released.
2002
The Baha
System is cleared
by the FDA to treat people
with single-sided deafness;
Softbands introduced for
children under the age of five.
Professor
Clark becomes an
Honorary Fellow of
the Royal Society of
Medicine.
ESPrit 3G for Nucleus 22
introduced. The processor
is the fifth upgrade for the
earliest Nucleus recipients.
2001
Cochlear Hybrid*
introduced. Combining
cochlear implant and hearing
aid technologies to
overcome high
frequency loss.
2002
Hybrid L24
Implant* is specifically
designed for sufferers of
high frequency hearing loss.
* Not
currently available in the
2009
Cochlear Nucleus 5 System
released, CP810 Sound
Processor.
2006
First Cochlear Celebration
held in Orlando, FL.
Celebration is now a
bi-annual tradition for
Cochlear recipients.
Baha Intenso released.
Cochlear announces
120,000 Nucleus cochlear
implant recipients.
2008
Nucleus 5 Upgrade for
Nucleus 24 implant
recipients.
Total number of
recipients helped by
Cochlear exceeds
250,000 worldwide.
Cochlear Baha 3 Released,
Baha BP100 Sound
Processor.
2012
Nucleus CI422 with Slim
approved by FDA – the
thinnest electrode uniquely
designed for preservation of
hearing structures.
Cochlear celebrates
30 years of changing lives.
2010
2007
2011
Baha 3 Power (BP110) the
thinnest programmable
power sound processor.
U.S. Caution: Investigational
device restricted to U.S.
FDA clinical studies.
2003–2004
Cochlear reaches more
than 60,000 Nucleus
recipients worldwide.
2000
2008
Cochlear moves the BoneAnchored Solutions business
unit to Denver.
2004
1998
Nucleus
Freedom
system released.
2005
2003
Heather Whitestone
McCallum becomes a Nucleus
recipient. She is the first
woman with a disability to be
crowned Miss America (1995).
2005
Cochlear establishes stateof-the-art headquarters
and manufacturing facility,
situated at Macquarie
University in Sydney, in
what will be one of the
world’s most unique
‘hearing precincts’, a
research and technology
hub dedicated to
pioneering the future
of hearing innovation.
Oldest cochlear implant
recipient at 102 years old
Nucleus Freedom available
for N22 implant recipients.
2005
2008
2009
2011